Eli Lilly (LLY) earnings Q3 2025

Eli Lilly on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro. Shares of the company rose more than 2% in morning trading on Thursday. The pharmaceutical giant now expects its…

Read More

Nikkei 225, Nifty 50, CSI 300

Mount Fuji and the Shinjuku skyline in Tokyo, Japan, on Friday, Feb. 14, 2025. Photographer: Kiyoshi Ota/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Asia-Pacific markets mostly traded higher on Wednesday as investors awaited the Federal Reserve’s interest rate decision, widely believed to bring a second straight 25 basis point cut. Markets are…

Read More